What if the future of healthcare isn’t defined by hospital visits, but by early insights that empower people to act before illness begins?
As Thailand faces the growing impact of NCDs (Non-Communicable Diseases) and an aging population, preventive healthcare is becoming a national priority. One innovation helping lead this shift is FonesVisuas—a blood protein analysis solution introduced in Thailand through a strategic partnership between NEC Thailand and N Health.
National Healthcare Systems Co., Ltd. or N Health, is a leading provider of laboratory diagnostic services in Thailand and a subsidiary of Bangkok Dusit Medical Services Public Company Limited (BDMS), the largest healthcare group in Southeast Asia. N Health delivers advanced diagnostic services to hospitals and medical institutions through a network of more than 80 branches across Thailand and overseas.
This milestone reflects NEC Thailand’s growing focus on healthcare as a strategic growth area, where advanced analytics and real-world impact converge. Ichiro Kurihara, President of NEC Thailand, shares, “Our approach focuses on preventing illness rather than reacting to it. By using technology, we help people understand their health better and feel confident about managing their future.”
FonesVisuas: Proven Innovation in Predictive Health
FonesVisuas is predictive health solution provided by FonesLife Corporation (subsidiary company under NEC Corporation) and delivered in Thailand under a signed agreement between NEC Thailand and N Health.
Using a single blood draw, FonesVisuas analyzes 7,000 proteins to identify early risk indicators for diseases such as cardiovascular disease, chronic kidney disease, lung cancer, prostate cancer, and dementia — years before symptoms appear.
Unlike traditional checkups, it requires no fasting, uses a small blood sample, and provides deeply personalized results. This shift from symptom-based care to preemptive action is a seismic leap in healthcare thinking.
Beyond its partnership with N Health, FonesVisuas has already gained traction among leading wellness and healthcare providers. Its adoption by internationally recognized wellness centers and hospital networks demonstrates growing confidence in data-driven preventive healthcare solutions.
“This isn’t just innovation; it’s empowerment,” Kurihara emphasized. “Preventive healthcare allows individuals to understand risks early and make informed decisions before conditions develop. That’s the real power of digital wellness.”
Narongrid Galaputh, Managing Director of N Health, highlighted the significance of the collaboration, “This collaboration with NEC marks an important milestone for N Health in elevating healthcare for the Thai population—from diagnostic testing toward predictive and preventive healthcare. FonesVisuas enables us to identify health risks at an early stage and leverage in-depth data to support personalized care. This approach not only helps reduce the long-term burden of disease but also contributes to building a more sustainable healthcare system for the country.”
The Future of Preventive Medicine
This momentum was reinforced during year-end when NEC joined the BDMS Academic Annual Meeting for the first time. During a dedicated lunch symposium, Dr. Iwao Waga, CTO of FonesLife Corporation (Japan), presented the role of proteomics in preventive medicine.
Through strategic partnerships, scientific expertise, and applied technology, NEC Thailand is advancing its business direction with a strong focus on healthcare in response to evolving customer needs. This marks an important new step for the company as it applies trusted, intelligent technologies to deliver.
Check your health risks early with just a small blood sample — simple, fast, and personalized! For more information about FonesVisuas Test, please contact N Health Customer Service at 02-7624000 press 1 or https://www.nhealth-asia.com/
For FonesVisuas innovation, please find more details at https://www.nec.com/en/global/corporateblog/202411/01.html